In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Zhejiang Conba Pharmaceutical Co., Ltd.

http://en.conbagroup.com/index.aspx

Latest From Zhejiang Conba Pharmaceutical Co., Ltd.

What Are Chinese Pharma CEOs Ranting About? (Part 2 of 2)

Top pharma executives get the chance to air their grievances during a once-a-year “meet the regulators” session in Beijing. In this second part of coverage of the meeting, China FDA director Wang Lifeng discusses marketing authorization holder pilots while CEOs including Betta’s Ding Lieming touch upon provincial tenders, orphan drugs and patent invalidity appeals.

BioPharmaceutical China

Asia Spotlight: China’s First TCM Law Excites Industry Looking For Cheer

A long-awaited new law that could greatly enlarge the market for traditional Chinese medicines has prompted domestic drug makers in China to race to develop new products, but could it also hurt multinational drug companies in the country?

BioPharmaceutical China

China Sows Ground For TCM Market Growth With Regulatory Framework

A long-awaited law could greatly enlarge the traditional Chinese medicine market and has prompted drug makers in the country to race to develop TCM products. The potential TCM boom has multinational drug firms leaping into the fray, some to partner with locals and others establishing teams devoted to TCM R&D.

Consumer BioPharmaceutical

China Sows Ground For TCM Market Growth With Regulatory Framework

A long-awaited law could greatly enlarge the traditional Chinese medicine market and has prompted drug makers in the country to race to develop TCM products. The potential TCM boom has multinational drug firms leaping into the fray, some to partner with locals and others establishing teams devoted to TCM R&D.

Consumer BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Nutraceuticals
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Conba Group Co. Ltd.
UsernamePublicRestriction

Register